Advisors Asset Management, Inc. Neurocrine Biosciences Inc Transaction History
Advisors Asset Management, Inc.
- $5.34 Billion
- Q2 2025
A detailed history of Advisors Asset Management, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 31,689 shares of NBIX stock, worth $4.48 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
31,689
Previous 36,761
13.8%
Holding current value
$4.48 Million
Previous $4.07 Million
2.04%
% of portfolio
0.07%
Previous 0.08%
Shares
29 transactions
Others Institutions Holding NBIX
# of Institutions
661Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.39 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$787 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$632 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$436 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.5B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...